Abstract: An imaging element includes a reading circuit that reads out pixel data obtained by imaging a subject at a first frame rate, a memory that stores the read pixel data, and an output circuit that outputs image data based on the stored pixel data at a second frame rate. The first frame rate is a frame rate higher than the second frame rate. The pixel data includes phase difference pixel data and non-phase difference pixel data different from the phase difference pixel data. The reading circuit reads out the pixel data of each of a plurality of frames in parallel within an output period defined by the second frame rate as a period in which the image data of one frame is output, and performs reading of the non-phase difference pixel data and a plurality of reading of the phase difference pixel data within the output period.

Abstract: An imaging apparatus includes a storage portion that stores captured image data obtained by imaging a subject by an imaging element and is incorporated in the imaging element, an output portion that is incorporated in the imaging element, and a plurality of signal processing portions that are disposed outside the imaging element, in which the output portion includes a plurality of output lines each disposed in correspondence with each of the plurality of signal processing portions and outputs each of a plurality of pieces of image data into which the captured image data stored in the storage portion is divided, to a corresponding signal processing portion among the plurality of signal processing portions from the plurality of output lines, and any of the plurality of signal processing portions combines the plurality of pieces of image data.

Abstract: There is provided a pit initiation evaluation system or the like capable of predicting pit initiation effectively and at low cost. In a pit initiation evaluation system of an embodiment, a pit initiation evaluation unit creates and retains, based on a dry-wet alternate time data, a deposit impurity concentration data, and a pit initiation data on pitting corrosion initiated in each of a plurality of turbine stages when an operation is actually performed in the steam turbine, a pit initiation evaluation table presenting a relationship between a dry-wet alternate time, a deposit impurity concentration, and pit initiation. Further, the pit initiation evaluation unit is configured to evaluate, by using the pit initiation evaluation table, pitting corrosion to be initiated in each of the plurality of turbine stages in an operation planned for the steam turbine.

Abstract: The present invention provides the following compounds having anti-viral activity. A1 is CR1AR1B, S or O; A2 is CR2AR2B, S or O; A3 is CR3AR3B, S or O; A4 is CR4AR4B, S or O; the number of hetero atoms among atoms constituting the ring which consists of A1, A2, A3, A4, nitrogen atom adjacent to A1 and carbon atom adjacent to A1, is 1 or 2; R1A and R1B are each independently hydrogen, halogen, alkyl, or the like; R2A and R2B are each independently hydrogen, halogen, alkyl, or the like; R3A and R3B are each independently hydrogen, halogen, alkyl, or the like; R4A and R4B are each independently hydrogen, halogen, alkyl, or the like; R3A and R3B may be taken together to form non-aromatic carbocycle or non-aromatic heterocycle; X is CH2, S or O; R1 is each independently halogen, hydroxy, or the like; m is any integer of 0 to 2; and n is any integer of 1 to 2.

Abstract: A state monitoring device monitors a state of a robot capable of playing back a predetermined operation. A time-series data acquirer acquires time-series data of state signals for a period of time from the timing of an acquisition start signal indicating a start of acquisition of a state signal reflecting a state of the robot to the timing of an acquisition end signal indicating an end of acquisition of the state signal. The time-series data is stored in association with timing information indicating the timing of acquisition and playback identification information identifying a playback operation of the robot. A dissimilarity calculator calculates dissimilarity between reference data based on the time-series data acquired in at least one operation and comparison data based on the time-series data acquired in an operation performed after the acquisition of the time-series data pertaining to the reference data.

Abstract: An analysis device includes: a first acquisition unit that acquires data indicating a first time zone in which each product stays in each of a plurality of processes; a second acquisition unit that acquires data indicating a second time zone in which a worker stays in each of the plurality of processes; an analyzer that analyzes a work situation for each product in each of the plurality of processes; and a providing unit that provides an analysis result. The analyzer determines, on the basis of a relationship between the first time zone and the second time zone in a period for analysis of a process for analysis, whether or not a factor that decreases work efficiency has occurred in the period for analysis of the process for analysis.

Abstract: The present invention provides a compound having antiviral activity, especially having arenavirus proliferation inhibitory activity, and/or a medicament comprising the compound. More preferably, the present invention provides a compound having proliferation inhibitory activity on the Old World arenaviruses such as Luna virus, Lassa virus, and lymphocytic choriomeningitis virus and/or the New World arenaviruses such as Junin virus, and/or a medicament comprising the compound. An arenavirus proliferation inhibitor comprising a compound represented by Formula (I) or a prodrug thereof or a pharmaceutically acceptable salt thereof.

Abstract: An information generation system according to the present invention includes: an acquiring unit configured to acquire activity place information representing a preset activity place of a user and user information representing a characteristic of the user; and a generating unit configured to generate, based on area information including target information representing an activity target which can be a target for an activity by the user in a predetermined area and based on the activity place information and the user information, activity plan information representing a new activity plan of the user including the target information corresponding to the user information.

Abstract: The present invention provides a compound having antiviral activity, especially having arenavirus proliferation inhibitory activity, and/or a medicament comprising the compound. More preferably, the present invention provides a compound having proliferation inhibitory activity on the Old World arenaviruses such as Luna virus, Lassa virus, and lymphocytic choriomeningitis virus and/or the New World arenaviruses such as Junin virus, and/or a medicament comprising the compound.

Abstract: A failure diagnosing device diagnoses failure of a plurality of reduction gears of a mechanical apparatus which includes a plurality of operation parts, a plurality of motors, and the plurality of reduction gears. The failure diagnosing device includes an acceleration/deceleration period identifying module configured to identify an acceleration/deceleration period of operation of one of the plurality of operation parts, a motor current processing module configured to acquire a peak value of an amplitude of a frequency component of motor current in a specific frequency band of one motor that drives the one operation part, in the acceleration/deceleration period, and a determining module configured to determine whether a sign of failure exists in one of the reduction gears.

Abstract: The present invention provides a pharmaceutical composition containing the following compound having antiviral action: P is hydrogen or a group to form a prodrug; A1 is CR1AR1B, S or O; A2 is CR2AR2B, S or O; A3 is CR3AR3B, S or O; A4 is each independently CR4AR4B, S or O; the number of hetero atoms among atoms constituting the ring which consists of A1, A2, A3, A4, nitrogen atom adjacent to A1 and carbon atom adjacent to A4, is 1 or 2; R1A and R1B are each independently hydrogen, halogen, alkyl, or the like; R2A and R2B are each independently hydrogen, halogen, alkyl, or the like; R3A and R3B are each independently hydrogen, halogen, alkyl, or the like; R4A and R4B are each independently hydrogen, halogen, alkyl, or the like; R3A and R3B may be taken together with an adjacent carbon atom to form non-aromatic carbocycle or non-aromatic heterocycle; R1 is fluorine; m is any integer of 1 to 2; and n is any integer of 1 to 2.

Abstract: The present invention provides a pharmaceutical composition containing the following compound having antiviral action: wherein each of the symbols is defined in the specification.

Abstract: A transmissive micro display board is manufactured without providing a light shielding layer. A manufacturing method of a micro display board includes the steps of: (i) forming a circuit layer on a surface of a first substrate provided with a single-crystal silicon layer; (ii) attaching a second substrate by using an adhesive to the surface of the first substrate on which the circuit layer has been formed; (iii) thinning a rear surface of the first substrate; (iv) attaching a third substrate being a transparent substrate to the thinned surface of the first substrate by using an adhesive; (v) removing the second substrate from the first substrate; and (vi) exposing a surface of the circuit layer by removing the adhesive on the surface of the first substrate after detaching the second substrate.

Abstract: A failure diagnosing device of a drive mechanism of a mechanical apparatus with a body including a motor, a speed reducer configured to slow down rotational power of the motor, and an operation part configured to operate by the slowed rotational power, and a vibration-proof controller configured to perform a vibration-proof control to prevent vibration of the body, the mechanism including the speed reducer and the motor. The device sends a command for suspending the vibration-proof control to the controller, then identifies an acceleration-and-deceleration period during which operation of the mechanical apparatus of which the control is suspended accelerates and decelerates, and determines whether the mechanism indicates a sign of failure based on a change in a frequency spectrum of load current of the motor or a current value having a correlation with the load current to a change in a rotational speed of the motor during the acceleration-and-deceleration period.

Abstract: A composite wafer having an oxide single-crystal film transferred onto a support wafer, the film being a lithium tantalate or lithium niobate film, and the composite wafer being unlikely to have cracking or peeling caused in the lamination interface between the film and the support wafer. More specifically, a method of producing the composite wafer, including steps of: implanting hydrogen atom ions or molecule ions from a surface of the oxide wafer to form an ion-implanted layer inside thereof; subjecting at least one of the surface of the oxide wafer and a surface of the support wafer to surface activation treatment; bonding the surfaces together to obtain a laminate; heat-treating the laminate at 90° C. or higher at which cracking is not caused; and exposing the heat-treated laminate to visible light to split along the ion-implanted layer to obtain the composite wafer.

Abstract: The present invention provides a compound having antiviral activity, especially having arenavirus proliferation inhibitory activity, and/or a medicament comprising the compound. More preferably, the present invention provides a compound having proliferation inhibitory activity on the Old World arenaviruses such as Luna virus, Lassa virus, and lymphocytic choriomeningitis virus and/or the New World arenaviruses such as Junin virus, and/or a medicament comprising the compound.

Abstract: A composite wafer having an oxide single-crystal film transferred onto a support wafer, the film being a lithium tantalate or lithium niobate film, and the composite wafer being unlikely to have cracking or peeling caused in the lamination interface between the film and the support wafer. More specifically, a method of producing the composite wafer, including steps of: implanting hydrogen atom ions or molecule ions from a surface of the oxide wafer to form an ion-implanted layer inside thereof, subjecting at least one of the surface of the oxide wafer and a surface of the support wafer to surface activation treatment; bonding the surfaces together to obtain a laminate; heat-treating the laminate at 90° C. or higher at which cracking is not caused; and applying a mechanical impact to the ion-implanted layer of the heat-treated laminate to split along the ion-implanted layer to obtain the composite wafer.

Abstract: The present invention provides a pharmaceutical composition containing the following compound having antiviral action: wherein each of the symbols is defined in the specification.

Abstract: The present invention provides a compound having antiviral effects, particularly having growth inhibitory activity on influenza viruses, a preferred example of the compound being a substituted 3-hydroxy-4-pyridone derivative prodrug having cap-dependent endonuclease inhibitory activity.

Abstract: Provided is a composite substrate which is provided with: a single crystal silicon carbide thin film 11 having a thickness of 1?m or less; a handle substrate 12 which supports the single crystal silicon carbide thin film 11 and is formed from a heat-resistant material (excluding single crystal silicon carbide) having a heat resistance of not less than 1,100° C.; and an intervening layer 13 which has a thickness of 1?m or less and is arranged between the single crystal silicon carbide thin film 11 and the handle substrate 12, and which is formed from at least one material selected from among silicon oxide, silicon nitride, aluminum oxide, aluminum nitride, zirconium oxide, silicon and silicon carbide, or from at least one metal material selected from among Ti, Au, Ag, Cu, Ni, Co, Fe, Cr, Zr, Mo, Ta and W. This composite substrate according to the present invention enables the formation of a nanocarbon film having few defects at low cost.